title: Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression.
authors.affiliation: Research Center, Louis H. Lafontaine Hospital, Montreal, Quebec, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Fontaine
authors.forename: A
authors.initials: A
authors.lastname: Ontiveros
authors.forename: R
authors.initials: R
authors.lastname: Elie
authors.forename: M
authors.initials: M
authors.lastname: Vézina
mesh_terms: D000328:Adult; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D003891:Desipramine / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage*; D006801:Humans; D008094:Lithium / Q000008:administration & dosage*; D016651:Lithium Carbonate; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales
chemical_list: D005473:Fluoxetine; D016651:Lithium Carbonate; D008094:Lithium; D003891:Desipramine